SDCCAG8 anticorps (Middle Region)

N° du produit ABIN632701

Détail du produit anti-SDCCAG8 anticorps

Antigène: SDCCAG8 (serologically Defined Colon Cancer Antigen 8 (SDCCAG8))

Épitope: Middle Region

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SDCCAG8 est non-conjugé

Application: Western Blotting (WB)

Specificité: SDCCAG8 antibody was raised against the middle region of SDCCAG8

Purification: Affinity purified

Immunogène: SDCCAG8 antibody was raised using the middle region of SDCCAG8 corresponding to a region with amino acids IQCDQLRKELERQAERLEKELASQQEKRAIEKDMMKKEITKEREYMGSKM

Information d'application

Indications d'application: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

SDCCAG8 Blocking Peptide, catalog no. 33R-4109, is also available for use as a blocking control in assays to test for specificity of this SDCCAG8 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SDCCAG8 antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur SDCCAG8

Antigène: SDCCAG8 (serologically Defined Colon Cancer Antigen 8 (SDCCAG8))

Autre désignation: SDCCAG8 (SDCCAG8 Produits)

Synonymes: anticorps si:dkey-60b15.1, anticorps BBS16, anticorps CCCAP, anticorps CCCAP SLSN7, anticorps NPHP10, anticorps NY-CO-8, anticorps SLSN7, anticorps hCCCAP, anticorps 2700048G21Rik, anticorps 5730470G24Rik, anticorps Cccap, anticorps serologically defined colon cancer antigen 8, anticorps sdccag8, anticorps SDCCAG8, anticorps Sdccag8

Sujet: SDCCAG8 encodes a centrosome associated protein. This protein may be involved in organizing the centrosome during interphase and mitosis. Mutations in this gene are associated with retinal-renal ciliopathy.

Poids moléculaire: 83 kDa (MW of target protein)

Pathways: M Phase, Tube Formation